A Single Cell Atlas of Lung Development
A Single Cell Atlas of Lung Development
About this item
Full title
Author / Creator
Negretti, Nicholas M , Plosa, Erin J , Benjamin, John T , Schuler, Bryce A , Habermann, A Christian , Jetter, Christopher , Gulleman, Peter , Taylor, Chase J , Nichols, David , Matlock, Brittany K , Guttentag, Susan H , Blackwell, Timothy S , Banovich, Nicholas E , Kropski, Jonathan A and Sucre, Jennifer M S
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Journal title
Language
English
Formats
Publication information
Publisher
Cold Spring Harbor: Cold Spring Harbor Laboratory Press
Subjects
More information
Scope and Contents
Contents
Summary Lung organogenesis requires precisely timed shifts in the spatial organization and function of parenchymal cells, especially during the later stages of lung development. To investigate the mechanisms governing lung parenchymal dynamics during development, we performed a single cell RNA sequencing (scRNA-seq) time-series yielding 92,238 epithelial, endothelial, and mesenchymal cells across 8 time points from embryonic day 12 (E12) to postnatal day 14 (P14) in mice. We combined new computational analyses with RNA in situ hybridization to explore transcriptional velocity, fate likelihood prediction, and spatiotemporal localization of cell populations during the transition between the saccular and alveolar stages. We interrogated this atlas to illustrate the complexity of type 1 pneumocyte function during the saccular and alveolar stages, and we demonstrate an integrated view of the cellular dynamics during lung development. Competing Interest Statement JAK has received advisory board fees from Boehringer Ingelheim, Inc and Janssen Therapeutics, grants from Boehringer Ingelheim, Inc, and has research contracts with Genentech. TSB has received advisory board fees from Boehringer Ingelheim, Inc, Orinove, GRI Bio, Morphic, and Novelstar, and has research contracts with Genentech and Celgene. Footnotes * Competing Interests JAK has received advisory board fees from Boehringer Ingelheim, Inc and Janssen Therapeutics, grants from Boehringer Ingelheim, Inc, and has research contracts with Genentech. TSB has received advisory board fees from Boehringer Ingelheim, Inc, Orinove, GRI Bio, Morphic, and Novelstar, and has research contracts with Genentech and Celgene. * Figures and supplemental files updated. * https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160876 * https://github.com/SucreLab/LungDevelopment...
Alternative Titles
Full title
A Single Cell Atlas of Lung Development
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2505703515
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2505703515
Other Identifiers
E-ISSN
2692-8205
DOI
10.1101/2021.01.21.427641
How to access this item
https://www.proquest.com/docview/2505703515?pq-origsite=primo&accountid=13902